Jasper Schoormans1, Claudia Calcagno2, Reza Indrakusuma3, Hamid Jalalzadeh3, Ron Balm3, Stefan Smorenburg4, Gustav J Strijkers1, Aart J Nederveen5, and Bram F Coolen1
1Department of Biomedical Engineering and Physics, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands, 2The BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, New York, NY, United States, 3Department of Surgery, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands, 4Department of Vascular Surgery, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands, 5Department of Radiology and Nuclear Medicine, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
Synopsis
We introduced 3D black-blood
DCE MRI in combination with AIF-free modeling to facilitate the measurement of
pharmacokinetic parameters in the aorta vessel wall of patients with an
abdominal aortic aneurysm. Our method enables 3D assessment of microvascularization and permeability which could assist a
clinical risk assessment of this condition.
Introduction
Dynamic
contrast-enhanced (DCE) magnetic resonance imaging (MRI) has been developed
into a powerful tool for the quantification of microvascularization and
permeability. When applied to vessel wall imaging, such as atherosclerotic
plaques and abdominal aortic aneurysms (AAA), a black-blood sequence is
preferred, since a very bright lumen signal can partly conceal perfusion
regions or cause artefacts related to blood motion. A volumetric
highly-accelerated vessel-wall black-blood DCE-MRI protocol was previously succesfully
demonstrated [1].
In
order to derive pharmacokinetic (PK) parameters one generally needs the arterial
input function (AIF). The AIF can be measured in combination with black-blood DCE
by interleaved bright/black blood sequences. However, these are
time-inefficient and complicate signal behavior. Unfortunately, the absence of
a patient-specific arterial input function (AIF) prevents most pharmacokinetic
modeling approaches. Moreover, many AIF-free alternatives are not valid for
highly vascularized regions.
To
overcome these issues, we propose the use of an AIF-free black-blood DCE method
and PK modeling employing the novel Constrained
Extended Reference Region Model (CERRM) [2], which can model the plasma fraction. This
model uses the concentration curve in a muscle reference region and uses this
to solve a reformulation of the Toft’s model. Instead of absolute values, the
resulting PK parameters are relative to those of the reference region.
We
have combined these methods and have included additional fit constraints to
prevent unphysical solutions. To demonstrate the feasibility of our new
approach, we performed DCE measurements in AAA patients. A scan-rescan study
was performed to analyze the reproducibility of the sequence-analysis pipeline. Methods
All
scans were performed with a 3T Philips Ingenia system. Four patients with an AAA
underwent a DCE-protocol with injection of Gadolinium (Magnevist). A 3D golden-angle
stack-of-stars TFE with iMSDE (improved motion-sensitized
driven equilibrium) black-blood preparation was performed (Fig. 1). To
assess reproducibility, a second scan was performed around one week after the
first.
Further
scan parameter were: FA=11°; TE/TR = 3.5/7.4 ms; TFE-factor = 35 resolution=1/1/2
mm3; temporal resolution=11 s/frame; total scan-time=10 minutes. A compressed
sensing reconstruction [3] was used with a temporal
total-variation constraint (lambda = 0.1). Reconstructions were performed on a
workstation with 2 NVIDIA Tesla P100 GPUs.
The
AAA vessel walls and a muscle region were manually segmented (Fig. 2) in
VesselMASS (Leiden University, the Netherlands). CERRM analysis was performed
in Matlab (Mathworks, USA) and Python. Signal intensity curves were converted
to concentration curves using the signal model described in [4]. Pre-contrast vessel-wall T1
and T2 values were fixed in the model. The voxel-wise ktrans, ref
maps were divided into three parts in the foot-head direction, and 12 parts in
the circular direction centered around the centroid of the segmentation (Fig. 2).
The mean in these subdivided regions was compared one-to-one between scan and rescan.
Subsequently, coefficients of variation (CoV) were calculated.PK-model
The
original CERRM method [2] is a least-squares solution of Ax=b, where A contains the signal
concentration and B is a matrix containing integrals of the muscle and
signal-of-interest concentrations. x is a vector containing linear combinations of the PK parameters. However, the global solution to this problem
may result in unphysical (negative) values for Ktrans. To prevent
this, we introduce additional constraints to this model, and solve it by
minimization of an l2 norm:
$$ \text{min} |A x - b|_2^2 \text{ subject to } k_{ep,rr} > 0 $$
It
can be shown that this constraint can be expressed by the following relation between
the elements of x:
$$ \text{min} |A x - b|_2^2 \text{ subject to } x_1^2 > 4 x_2 x_3$$
Similarly,
in the second step of [2] we added additional constraints:
$$ \text{min} |G y - b|_2^2 \text{ subject to } y_1 > y_2 y_3$$Results & discussion
Fig.
3A shows pre- and post-contrast DCE images of the AAA of one patient. Regions
of lower and higher enhancement can be clearly identified. A voxelwise Ktrans,ref
map of both the scan and rescan (Fig. 3B) shows good spatial correspondence of
the high and the low enhancement regions.
The
constrained fit lowers the CoV from 66% to 49%, it also removes the bias (Fig.
4). Additionally, the constraint has removed unphysical values entirely
(negative Ktrans, negative Ve, Vp). Also, the fit cost has substantially lowered,
while the overall Ktrans,ref distribution is similar (Fig. 5).
Nguyen
[5] found a AAA scan-rescan CoV of
38% in a 2D bright-blood sequence with a Patlak fit. We found a CoV that is
slightly lower. We think this is due to mis-registration between scan and
rescan which could be improved by elastric registration. Conclusion
We
introduced 3D black-blood DCE MRI in combination with AIF-free modeling to
facilitate the measurement of pharmacokinetic parameters in the aorta vessel
wall of patients with an abdominal aortic aneurysm. Our method enables 3D assessment
of microvascularization
and permeability which could assist a clinical risk assessment of this condition. Acknowledgements
No acknowledgement found.References
[1] J.
Schoormans, K. Zheng, E. Stroes, G. Strijkers, A. Nederveen, and B. Coolen, “3D
Black-Blood DCE-MRI Using Radial Stack-Of-Stars Acquisition and CS
Reconstruction: Application in Carotid and Femoral Arteries,” in Proceedings
of the Annual Meeting of the ISMRM, 2017.
[2] Z.
Ahmed and I. R. Levesque, “An extended reference region model for DCE-MRI that
accounts for plasma volume,” NMR Biomed., vol. 31, no. 7, pp. 1–13,
2018.
[3] L.
Feng, L. Axel, H. Chandarana, K. T. Block, D. K. Sodickson, and R. Otazo, “XD-GRASP:
Golden-angle radial MRI with reconstruction of extra motion-state dimensions
using compressed sensing,” Magn. Reson. Med., vol. 75, no. 2, pp. 775–788,
2016.
[4] H.
Qi, F. Huang, Z. Zhou, P. Koken, N. Balu, B. Zhang, C. Yuan, and H. Chen, “Large
coverage black-bright blood interleaved imaging sequence (LaBBI) for 3D dynamic
contrast-enhanced MRI of vessel wall,” Magn. Reson. Med., vol. 79, no.
3, pp. 1334–1344, 2018.
[5] V.
L. Nguyen, M. E. Kooi, W. H. Backes, R. H. M. van Hoof, A. E. C. M. Saris, M.
C. J. Wishaupt, F. A. M. V. I. Hellenthal, R. J. van der Geest, A. G. H.
Kessels, G. W. H. Schurink, and T. Leiner, “Suitability of Pharmacokinetic
Models for Dynamic Contrast-Enhanced MRI of Abdominal Aortic Aneurysm Vessel
Wall: A Comparison,” PLoS One, vol. 8, no. 10, pp. 6–12, 2013.